The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.
about
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003Hormone therapy discontinuation: physician practices after the Women's Health Initiative.Hormone therapy and fatal breast cancer.The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
P2860
The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The impact of comorbidities on ...... the Women's Health Initiative.
@ast
The impact of comorbidities on ...... the Women's Health Initiative.
@en
The impact of comorbidities on ...... the Women's Health Initiative.
@nl
type
label
The impact of comorbidities on ...... the Women's Health Initiative.
@ast
The impact of comorbidities on ...... the Women's Health Initiative.
@en
The impact of comorbidities on ...... the Women's Health Initiative.
@nl
prefLabel
The impact of comorbidities on ...... the Women's Health Initiative.
@ast
The impact of comorbidities on ...... the Women's Health Initiative.
@en
The impact of comorbidities on ...... the Women's Health Initiative.
@nl
P2093
P2860
P1476
The impact of comorbidities on ...... the Women's Health Initiative.
@en
P2093
Cynthia L Hartsfield
Diana L Miglioretti
Diana S M Buist
Feifei Wei
K Arnold Chan
Katherine M Newton
Kevin Beverly
Larry Kessler
Maureen T Connelly
Susan E Andrade
P2860
P304
P356
10.1111/J.1525-1497.2005.04059.X
P577
2005-04-01T00:00:00Z
P5875
P6179
1037112352